Abstract

B-Lymphotropic Polyomavirus (LPyV) serves as a paradigm of virus receptor binding and tropism, and is the closest relative of the recently discovered Human Polyomavirus 9 (HPyV9). LPyV infection depends on sialic acid on host cells, but the molecular interactions underlying LPyV-receptor binding were unknown. We find by glycan array screening that LPyV specifically recognizes a linear carbohydrate motif that contains α2,3-linked sialic acid. High-resolution crystal structures of the LPyV capsid protein VP1 alone and in complex with the trisaccharide ligands 3′-sialyllactose and 3′-sialyl-N-acetyl-lactosamine (3SL and 3SLN, respectively) show essentially identical interactions. Most contacts are contributed by the sialic acid moiety, which is almost entirely buried in a narrow, preformed cleft at the outer surface of the capsid. The recessed nature of the binding site on VP1 and the nature of the observed glycan interactions differ from those of related polyomaviruses and most other sialic acid-binding viruses, which bind sialic acid in shallow, more exposed grooves. Despite their different modes for recognition, the sialic acid binding sites of LPyV and SV40 are half-conserved, hinting at an evolutionary strategy for diversification of binding sites. Our analysis provides a structural basis for the observed specificity of LPyV for linear glycan motifs terminating in α2,3-linked sialic acid, and links the different tropisms of known LPyV strains to the receptor binding site. It also serves as a useful template for understanding the ligand-binding properties and serological crossreactivity of HPyV9.

Highlights

  • The B-Lymphotropic Polyomavirus (LPyV) was originally isolated from African Green Monkey lymph node cultures [1] and attracted interest because of its narrow tropism for the human B-lymphoblastoid tumor cell line BJA-B

  • We have characterized the structural requirements for receptor binding of B-lymphotropic polyomavirus (LPyV)

  • This virus was originally isolated from African Green Monkey lymph node cultures and attracted interest because of its narrow tropism for a human tumor cell line

Read more

Summary

Introduction

The B-Lymphotropic Polyomavirus (LPyV) was originally isolated from African Green Monkey lymph node cultures [1] and attracted interest because of its narrow tropism for the human B-lymphoblastoid tumor cell line BJA-B. Several members of the polyomavirus family, such as Simian Virus 40 (SV40), can transform cells in culture and cause tumors in animals [3,4]. Infections by the human JC and BK Polyomaviruses (JCPyV and BKPyV, respectively) remain subclinical in healthy individuals and cause severe acute disease, not cancer, in immunocompromised patients [6]. It is not known whether LPyV is endemic in humans, but a closely related virus, Human Polyomavirus 9 (HPyV9), was identified in 2011 and detected in human serum, plasma, urine and skin [7,8]. There are no data yet on the pathogenicity of HPyV9 in the human population, the seroprevalence is 47% in adults [9]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.